- Home
- BBIO vs CAG Comparison
BBIO vs CAG Comparison
Compare BBIO & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- CAG
- Stock Information
- Founded
- BBIO 2015
- CAG 1919
- Country
- BBIO United States
- CAG United States
- Employees
- BBIO N/A
- CAG N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- CAG Packaged Foods
- Sector
- BBIO Health Care
- CAG Consumer Staples
- Exchange
- BBIO Nasdaq
- CAG Nasdaq
- Market Cap
- BBIO 8.8B
- CAG 9.7B
- IPO Year
- BBIO 2019
- CAG N/A
- Fundamental
- Price
- BBIO $47.27
- CAG $18.27
- Analyst Decision
- BBIO Strong Buy
- CAG Hold
- Analyst Count
- BBIO 16
- CAG 10
- Target Price
- BBIO $61.50
- CAG $21.90
- AVG Volume (30 Days)
- BBIO 2.2M
- CAG 13.0M
- Earning Date
- BBIO 08-05-2025
- CAG 07-10-2025
- Dividend Yield
- BBIO N/A
- CAG 7.67%
- EPS Growth
- BBIO N/A
- CAG 233.33
- EPS
- BBIO N/A
- CAG 2.40
- Revenue
- BBIO $127,415,000.00
- CAG $11,612,800,000.00
- Revenue This Year
- BBIO $106.33
- CAG $0.45
- Revenue Next Year
- BBIO $54.30
- CAG N/A
- P/E Ratio
- BBIO N/A
- CAG $7.61
- Revenue Growth
- BBIO N/A
- CAG N/A
- 52 Week Low
- BBIO $21.72
- CAG $18.19
- 52 Week High
- BBIO $48.68
- CAG $33.24
- Technical
- Relative Strength Index (RSI)
- BBIO 64.57
- CAG 28.52
- Support Level
- BBIO $45.11
- CAG $18.95
- Resistance Level
- BBIO $47.11
- CAG $19.43
- Average True Range (ATR)
- BBIO 1.40
- CAG 0.45
- MACD
- BBIO -0.26
- CAG 0.02
- Stochastic Oscillator
- BBIO 60.53
- CAG 5.01
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of fiscal 2024 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2024 revenue coming from international markets and 10% from foodservice.